By Shania Kennedy
June 29, 2023 – Researchers have developed a generative artificial intelligence (AI) model capable of designing novel molecules to block SARS-CoV-2, the virus that causes COVID-19, according to a study published in Science…
Continue Reading
A growing number of organisations are leveraging blockchain technology to improve services in the healthcare industry. Because of its diverse applications, including medical supply chain management, patient data security, and drug discovery, blockchain is…
Continue Reading
What You Should Know:
The AI in Drug Discovery market in terms of revenue was estimated to be worth $600M in 2022 and is poised to reach $4B by 2027, growing at a CAGR of…
Continue Reading
Nathan Sommerford, Global Lead for Drug Discovery and Development, IQVIA
In an interview with HIT Consultant, Nathan Sommerford, Global Lead for Drug Discovery and Development, IQVIA talks how unlocking artificial intelligence (AI) in drug repurposing…
Continue Reading
Google Cloud has unveiled two new artificial intelligence (AI) tool suites, already adopted by firms like Pfizer and Colossal Biosciences, aimed at enhancing drug discovery and precision medicine. The Target and Lead Identification Suite…
Continue Reading
Pfizer and Colossal Biosciences are among the biotech and pharma firms already using two new suites of artificial intelligence tools unveiled this week by Google Cloud.WHY IT MATTERSThe new technologies, announced for general availability…
Continue Reading
News
AI-powered drug discovery could represent a $50 billion opportunity for big pharma according to a Bloomberg article, which notes that one drug company paid $4 billion for drug that was developed by a startup…
What You Should Know:The drug discovery outsourcing market is expected to reach $3.75B in 2023 and is expected to grow at a steady CAGR of 7.2% and is expected to reach $7.52B by 2033, according to…
Continue Reading
What You Should Know:– PsychoGenics Inc., a provider of AI-enabled phenotypic drug discovery and preclinical CRO services launches eCube®, a novel pharmaco-electroencephalography (“pharmacoEEG”) platform.The platform supports phenotypic drug discovery, which unlike traditional target-based drug…
Continue Reading
What You Should Know:Genialis, a computational precision medicine company unraveling complex biology to find new ways to address disease, today announced it raised more than $13 million in Series A financing to transform the…
Continue Reading
